IRBESARTAN JENSON PHARMACEUTICAL SERVICES 150 MG

Základní informace

  • Název přípravku:
  • IRBESARTAN JENSON PHARMACEUTICAL SERVICES 150 MG, POR TBL NOB 500X150MG
  • Dávkování:
  • 150MG
  • Léková forma:
  • Tableta
  • Podání:
  • Perorální podání
  • Jednotky v balení:
  • 500, Obal na tablety
  • Druh předpisu:
  • Léčiva na lékařský předpis
  • Použij pro:
  • Lidé
  • Léčitelství typu:
  • alopatický drog

Dokumenty

Lokalizace

  • K dispozici v:
  • IRBESARTAN JENSON PHARMACEUTICAL SERVICES 150 MG, POR TBL NOB 500X150MG
    Česká republika
  • Jazyk:
  • čeština

Další informace

Stav

  • Zdroj:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Stav Autorizace:
  • B - přípravek po provedené změně.
  • Registrační číslo:
  • 58/ 069/12-C
  • Datum autorizace:
  • 31-10-2012
  • Poslední aktualizace:
  • 08-11-2016

30-11-2017

Nutra Labs Inc. Issues Voluntary Nationwide Recall of Dietary Supplements Bull and Chao Jimengnan Tablets Due to Undeclared Active Pharmaceutical Ingredients

Nutra Labs Inc. Issues Voluntary Nationwide Recall of Dietary Supplements Bull and Chao Jimengnan Tablets Due to Undeclared Active Pharmaceutical Ingredients

Nutra Labs Inc. is voluntarily recalling lots sold by their firm of the male enhancement supplements Bull 1800 mg Capsules with the production date of 05/08/2016, and Chao Jimengnan 150 mg Tablets with Lot # 20151018 to the consumer level. FDA analysis found the products to be tainted with sildenafil, 0.026mg/capsule for Bull, and 70.46mg/tablet for Chao Jimengnan respectively. Sildenafil is the active pharmaceutical ingredient in an FDA approved product used for erectile dysfunction, making Bull capsule...

FDA - U.S. Food and Drug Administration

25-9-2017

 Global operation against illegal medicines

Global operation against illegal medicines

A global operation against illegal medicines has been completed. 123 countries participated, and the operation resulted in 354 arrests or further investigations and the suspension of more than 3,500 websites. Illegal sale of medicines is an increasing problem that may pose a global threat to public health. Sales often take place over the internet and across geographical borders. Consequently, the Danish Medicines Agency, the Danish Veterinary and Food Administration, the Danish Customs and Tax Administr...

Danish Medicines Agency

17-1-2018

Irbesartan

Irbesartan

Irbesartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems.

US - RxList

30-8-2017

Irbesartan HCT Zentiva (Sanofi-Aventis groupe)

Irbesartan HCT Zentiva (Sanofi-Aventis groupe)

Irbesartan HCT Zentiva (Active substance: irbesartan / hydrochlorothiazide) - PSUSA - Modification - Commission Decision (2017)5986 of Wed, 30 Aug 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/783/PSUSA/00001653/201609

Europe -DG Health and Food Safety

25-8-2017

hydrochlorothiazide / irbesartan

hydrochlorothiazide / irbesartan

hydrochlorothiazide / irbesartan (Active substance: hydrochlorothiazide / irbesartan) - Centralised - Art 28 - (PSUR - Commission Decision (2017)5946 of Fri, 25 Aug 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/1653/201609

Europe -DG Health and Food Safety

7-7-2017

IRBESARTAN (Irbesartan ) Tablet [ScieGen Pharmaceuticals, Inc.]

IRBESARTAN (Irbesartan ) Tablet [ScieGen Pharmaceuticals, Inc.]

Updated Date: Jul 7, 2017 EST

US - DailyMed

14-6-2017

Irbesartan Teva (Teva B.V.)

Irbesartan Teva (Teva B.V.)

Irbesartan Teva (Active substance: Irbesartan) - Centralised - Yearly update - Commission Decision (2017)4169 of Wed, 14 Jun 2017

Europe -DG Health and Food Safety